Rating History for Galera Therapeutics (GRTX) by Citi
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/11/2023 | Yigal Nochomovitz | Downgrade | Neutral (Buy) |
0.40 (12.00) |
0.36 (0.15) |
-58.33% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/11/2023 | Yigal Nochomovitz | Downgrade | Neutral (Buy) |
0.40 (12.00) |
0.36 (0.15) |
-58.33% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||